CYTOSORBENTS CORPORATI

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

04 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

CytoSorbents Reports First Quarter 2024 Results

09 مايو 2024 15:17:23 بحسب Nasdaq GlobeNewswire

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

02 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

26 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

17 أبريل 2024 08:45:06 بحسب NetDania Notify

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

17 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

16 أبريل 2024 08:57:39 بحسب NetDania Notify

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

14 مارس 2024 15:39:31 بحسب Nasdaq GlobeNewswire

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

06 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

08 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

25 يناير 2024 09:26:32 بحسب NetDania Notify

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

17 يناير 2024 06:15:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

08 يناير 2024 09:16:09 بحسب NetDania Notify

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

28 ديسمبر 2023 08:48:08 بحسب NetDania Notify

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

28 ديسمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

13 ديسمبر 2023 08:15:00 بحسب Nasdaq GlobeNewswire

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

09 نوفمبر 2023 15:15:00 بحسب Nasdaq GlobeNewswire

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results

27 أكتوبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

CytoSorbents to Present at the 8th Annual Dawson James Conference

05 أكتوبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

27 سبتمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire